Gene · 8434
Papers1,933
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,933
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In silico whole-transcriptome analysis reveals a potential hsa_circ_0000375-miR-424-5p-TPM2/SRPX/SRGAP1 regulatory network related to liver metastasis of colorectal cancer. | Heliyon | 2023 | 37954397 | PubTator, text mining | PubMed |
| Identification of RECK as a protective prognostic indicator and a tumor suppressor through regulation of the ERK/MAPK signaling pathway in gastric cancer. | J Transl Med | 2023 | 37904179 | PubTator, text mining | PubMed |
| The Roles of Histone Deacetylases in the Regulation of Ovarian Cancer Metastasis. | Int J Mol Sci | 2023 | 37894746 | PubTator, text mining | PubMed |
| The Potential Role of Circulating Long Miscellaneous RNAs in the Diagnosis and Prognosis of Hepatitis C Related Hepatocellular Carcinoma. | Noncoding RNA | 2023 | 37888208 | PubTator, text mining | PubMed |
| HPV16E1 downregulation altered the cell characteristics involved in cervical cancer development. | Sci Rep | 2023 | 37880374 | PubTator, text mining | PubMed |
| Advances in understanding and treating diabetic kidney disease: focus on tubulointerstitial inflammation mechanisms. | Front Endocrinol (Lausanne) | 2023 | 37859992 | PubTator, text mining | PubMed |
| Pathogenic signal peptide variants in the human genome. | NAR Genom Bioinform | 2023 | 37859801 | PubTator, text mining | PubMed |
| The anti-tumor potential of sinomenine: a narrative review. | Transl Cancer Res | 2023 | 37859743 | PubTator, text mining | PubMed |
| Molecular basis of Wnt biogenesis, secretion, and Wnt7-specific signaling. | Cell | 2023 | 37852257 | PubTator, text mining | PubMed |
| The Characteristics of Concurrent Anti-Glomerular Basement Membrane Nephritis and Membranous Nephropathy. | Kidney Int Rep | 2023 | 37850023 | PubTator, text mining | PubMed |
| Prognostic and immunological role of acetaldehyde dehydrogenase 1B1 in human tumors: A pan-cancer analysis. | Int J Immunopathol Pharmacol | 2023 | 37847172 | PubTator, text mining | PubMed |
| Overexpression of miR-146a and miR-155 are Potentially Biomarkers and Predict Unfavorable Relationship between Gastric Cancer and Helicobacter pylori Infection. | Chonnam Med J | 2023 | 37840673 | PubTator, text mining | PubMed |
| A Narrative Review on CD44's Role in Glioblastoma Invasion, Proliferation, and Tumor Recurrence. | Cancers (Basel) | 2023 | 37835592 | PubTator, text mining | PubMed |
| The Effect of Gene Editing by CRISPR-Cas9 of miR-21 and the Indirect Target MMP9 in Metastatic Prostate Cancer. | Int J Mol Sci | 2023 | 37834295 | PubTator, text mining | PubMed |
| Empagliflozin Reverses Oxidized LDL-Induced RECK Suppression, Cardiotrophin-1 Expression, MMP Activation, and Human Aortic Smooth Muscle Cell Proliferation and Migration. | Mediators Inflamm | 2023 | 37830075 | PubTator, text mining | PubMed |
| Role of LncRNA MIR99AHG in breast cancer: Bioinformatic analysis and preliminary verification. | Heliyon | 2023 | 37809464 | PubTator, text mining | PubMed |
| Phosphorylation of EZH2 differs HER2-positive breast cancer invasiveness in a site-specific manner. | BMC Cancer | 2023 | 37803297 | PubTator, text mining | PubMed |
| The contribution of matrix metalloproteinases and their inhibitors to the development, progression, and rupture of abdominal aortic aneurysms. | Front Cardiovasc Med | 2023 | 37799778 | PubTator, text mining | PubMed |
| When Bacteria and Viruses Collide: A Tale of Chlamydia trachomatis and Sexually Transmitted Viruses. | Viruses | 2023 | 37766360 | PubTator, text mining | PubMed |
| Salvianolic Acid B: A Review of Pharmacological Effects, Safety, Combination Therapy, New Dosage Forms, and Novel Drug Delivery Routes. | Pharmaceutics | 2023 | 37765204 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8434/papers?page=5